SCHEMBL25558993

SCHEMBL25558993

O=Cc1ccccc1P=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ THRB P10828 1/20 0.57
▸ BLM P54132 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ ALDH1A1 P00352 5/20 0.46
▸ TRIM24 O15164 2/20 0.46
▸ TRIM33 Q9UPN9 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ HPGD P15428 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ GAA P10253 1/20 0.39
▸ ERN1 O75460 2/20 0.38
▸ SRC P12931 1/20 0.36
▸ CYP2A6 P11509 4/20 0.36
▸ IMPDH2 P12268 1/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28928203 0.93 LMNA (0.50) LMNAKMT2AMEN1THRBBLM
SCHEMBL29197892 0.79 KMT2A (0.44) LMNAKMT2AMEN1THRBBLM
SCHEMBL28958589 0.78 ALDH1A1 (0.44) LMNAKMT2AMEN1THRBBLM
SCHEMBL7245064 0.74 MEN1 (0.32) LMNAKMT2AMEN1THRBBLM
Ortho-Phthalaldehyde SCHEMBL33393 0.74 LMNA (1.00) LMNAKMT2AMEN1THRBBLM
Ortho-Phthalaldehyde SCHEMBL4953869 0.74 LMNA (1.00) LMNAKMT2AMEN1THRBBLM
Ortho-Phthalaldehyde SCHEMBL29412642 0.74 LMNA (1.00) LMNAKMT2AMEN1THRBBLM
SCHEMBL28465753 0.73 NFE2L2 (0.50) LMNAKMT2AMEN1ALDH1A1SMN1; SMN2
Ortho-Phthalaldehyde SCHEMBL10792496 0.72 LMNA (0.93) LMNAKMT2AMEN1THRBBLM
Ortho-Phthalaldehyde SCHEMBL6688449 0.72 LMNA (0.93) LMNAKMT2AMEN1THRBBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151035-A1 Preparation method for and application of chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligand and iridium catalyst thereof ZHEJIANG JIUZHOU PHARM CO LTD (CN) 2023-05-18 — — US disclosed
CN-108003309-A A kind of phenolic resin curing agent and preparation method thereof 嘉兴市东方化工厂 2018-05-08 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151035-A1 Preparation method for and application of chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligand and iridium catalyst thereof SPR, PKD1, ROR1 LMNA 4595/4885KMT2A 3210/4885MEN1 1762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback